To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min While Biogen's new CEO says he ...

BOSTON (AP) — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs, ...

A game of real estate musical chairs is underway in Kendall Square as Biogen hands the deed from one of its East Coast sites to office aficionado Boston Properties (BXP). Wednesday, the Big Biotech ...

Leqembi, which was approved in 2023 to treat the mind-robbing disease, generated $168 million in sales, up 74 percent from ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Biogen Inc. has sold a six-floor ...

Naomi Fried, Boston Children’s Hospital’s Chief Innovation Officer, is leaving the hospital to become Vice President of Medical Information, Innovation, and External Partnerships at Biogen Idec, ...

Cambridge-based life sciences company Biogen has put over 263K SF of office space in two buildings in Cambridge and Weston on the sublease market. The company has listed more than 183K SF at 300 ...

Chris Viehbacher defended the $26,500 annual price for Leqembi, days after an advisory panel recommended it for expanded approval Three days after an influential advisory panel recommended expanded US ...

Join RAPS Boston for an in-person Executive Chat with Diane Rocco, SVP of Global Regulatory Affairs at Biogen, moderated by Ami Mehr. The discussion will explore how regulatory leadership shapes key ...